Schrdinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science⦠read more
Healthcare
Health Information Services
3 years
USD
Exclusive to Premium users
$19.04
Price-0.47%
-$0.09
$1.401b
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$237.917m
-
1y CAGR-
3y CAGR-
5y CAGR-$181.333m
-
1y CAGR-
3y CAGR-
5y CAGR-$2.48
-
1y CAGR-
3y CAGR-
5y CAGR$342.872m
$688.244m
Assets$345.372m
Liabilities$114.313m
Debt16.6%
-0.6x
Debt to EBITDA$24.371m
-
1y CAGR-
3y CAGR-
5y CAGR